September 29, 2023

Emendo Biotherapeutics Leaders Share Expert Insights on Cutting-Edge Gene Editing Advancements at October Industry Conferences

EmendoBio More
August 1, 2023

EmendoBio Scientists Participate in National Neutropenia Network Patient Retreat

EmendoBio More
June 9, 2023

Base Editors and Prime Editors Begin to Realize Their Clinical Promise

GEN More
June 24, 2022

Mutant allele knockout with novel CRISPR nuclease promotes myelopoiesis in ELANE neutropenia

Cell More
April 24, 2022

Emendo Biotherapeutics to present at the American Society of Gene & Cell Therapy annual conference

Press Release More
December 16, 2021

CRISPR innovation hits the gas

Biocentury More
December 15, 2020

EmendoBio Gene Editing Company Acquired by AnGes, Inc.

Press Release More
January 15, 2020

Takeda hops onto $61M round for CRISPR player synthesizing Cas9 alternatives

Endpoint News More